News & Events

WATCH LIVE – Vancouver City Council votes on drug decriminalization today

At 9:30 a.m. today, Mayor Kennedy Stewart will be proposing a groundbreaking motion to the Vancouver City Council and a formal vote will ensue. Announced last Wednesday, Nov. 18th, the Mayor is hoping to make Vancouver the first Canadian city to decriminalize drug possession. This is said to be a response to the opiate crisis, not a magic solution; it’s about approaching from a harm reduction standpoint, reducing stigma, and treating addiction as a health issue. In August 2016, officials in BC declared the opiate epidemic to be a public health emergency but overdose rates continue to rise.  Mayor Steward […]

Share

Vancouver’s Decriminalization Plan From A Legal Perspective

Vancouver has made a big step forward in the possible decriminalization of drugs. Last week, Vancouver Mayor Kennedy Stewart announced the cities intention to seek leave from the federal government to approve a plan to decriminalize simple possession of illicit drugs within city limits.  Stewart described these types of offenses as a health issue, rather than a criminal justice issue.  He also talked about the stigma associated with substance misuse and the need to change our views on this behavior as an essential step in the fight against opioid overdoses.    If the plan receives federal approval, it will be the first jurisdiction […]

Share

Numinus Announces Clinical Trial Of Psilocybin-Assisted Psychotherapy

Vancouver based Numinus Wellness Inc. announced early this morning that it will undertake a clinical trial of psilocybin-assisted psychotherapy. The compassionate access clinical trial will enable the company to refine optimal protocols for the use of psilocybin-assisted psychotherapy for participants with a range of substance use disorders. About the Research & Clinical Trial Numinus Wellness Inc. will conduct the study in collaboration with Syreon Corporation. Syreon is a global contract research organization with expertise in conducting clinical trials across a wide variety of diseases. The study will involve an initial 30 participants. These participants will take part in motivational enhancement […]

Share